secwatch.observer — SEC 8-K summary
======================================

Issuer:     Health Catalyst, Inc. (HCAT)
CIK:        0001636422
Form:       8-K
Filed at:   2024-08-07T23:59:59+00:00
Accession:  0001636422-24-000116
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Health Catalyst beats Q2 2024 guidance: revenue $75.9M, Adj. EBITDA $7.5M
-------------------------------------------------------------------------

- Total revenue $75.9M (+4% YoY); net loss $13.5M vs $32.6M loss in Q2 2023.
- Adjusted EBITDA $7.5M, exceeding guidance midpoint of $6.0M.
- Reiterates FY 2024 revenue $304-312M and Adj. EBITDA $24-26M; Q3 rev guidance $74.5-77.5M.
- Signed more net new platform subscription clients in 1H 2024 than all of 2023; targeting low-20s for FY.
- Announced $225M credit facility with Silver Point Finance and acquisitions of Carevive and Lumeon.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1636422/000163642224000116/0001636422-24-000116-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1636422/000163642224000116/hcat-20240807.htm
  HTML page:      https://secwatch.observer/filing/0001636422-24-000116

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer